Analyzing Gait Pattern Using Insole-type Gait Analyzer in Patient With Gait Disturbance
ConditionGait Disorders, Neurologic
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorYonsei University
About this trial
The goal of this clinical trial is to explore the usefulness of information from insole-type gait analyzer in adults with subjective gait and balance disorders.
The main questions it aims to answer are:
How useful is an insole-type gait analyzer for collecting gait data from patients with gait disturbances?
Researchers will explore the usefulness of collected data and does not establish a control group.
Participants will:
Participants will conduct survey and perform the Timed up and go test wearing an insole-type gait analyzer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adults aged 19 and over (based on the age on their national ID at the time of consent)
adults complaining subjective gait or balance disorders
individuals who voluntarily agree to participate in the study and sign a consent form
Disqualifiers
individuals unable to walk independently on flat ground for more than 6 minutes
individuals who cannot read ordinary print with glasses due to visual reasons
individuals who cannot understand conversation even with a hearing aid due to auditory reasons
individuals with clinically significant disorders in the cardiovascular, gastrointestinal, respiratory, or endocrine systems
Trial design
Design model
Single group
Treatments tested in this trial
insole-type gait analyzer
DevicePatients with subjective gait and balance disorders will wear insole-type gait analyzer and walk, then the collected data will be examined.
Treatment groups
600 Participants
are divided into 1 treatment groupGroup A: Insole wearing groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Timed up and go test (TUG)
The participants will wear insole-type gait analyzer and undergo the Timed Up and Go test. The above test assesses walking speed along with balance ability during walking, and this is performed as follows. 1. A 46 cm high armrest chair, a color cone is placed at a distance of 3 meters from the chair and the subject is instructed to sit on the chair. 2. In the preparation phase, the subject leans against the chair backrest and places his/her arms on the armrests, then stands up on the instruction "Start", walks 3 meters, turns around the color cone, returns to the starting point and sits down on the chair. 5\) Data Verification The measurement values of the accelerometer and pressure sensors recorded in the insole-type gait analyzer will be examined to determine the presence of missing or outlier data. The investigators will explore the data collection frequency and analysis methods to extract clinically significant data.
Time frame
TUG test session will last approximately 5 minutes. and TUG test will be performed at baseline.2
Korean version of Sarcopenia Screening Questionnaire
Questionnaire that evaluates the decrease in muscle strength and functional performance along with a decrease in muscle mass and it is highly related to aging and chronic diseases. The evaluation method is conducted by having the examiner ask the subject about the following questionnaire, and the scores for the answers are recorded. It consists of 5 questions, and each question is scored 0-2 points. The higher the score, the higher the risk of sarcopenia. If the score is 4 or higher, sarcopenia may be suspected.
Time frame
This K-SSQ session will last approximately 1 minutes, it will be performed at baseline.3
Korean version of the International Physical Activity Questionnaire (K-IPAQ)
Tests that assess various aspects of an individual's daily physical activity16 and it can provide information about activity level. The examiner questions the subject based on the questionnaire below, records related information, calculates the total activity time and intensity, and classifies it as 'low', 'medium', and 'high'.
Time frame
This K-IPAQ session will last approximately 3 minutes, it will be performed at baseline.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov